New drug ARGX-213 tested in healthy people for safety
NCT ID NCT06968338
First seen Nov 21, 2025 · Last updated May 21, 2026 · Updated 19 times
Summary
This early-stage study tested the safety of a new drug called ARGX-213 in 88 healthy adults. Researchers measured how the drug moves through the body and checked for side effects. Participants were monitored for up to 21 weeks. This study does not aim to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Altasciences
Montreal, QC H3P 3P1, Canada
Conditions
Explore the condition pages connected to this study.